about
Distinctive Clinical Effects of Haemorrhagic Markers in Cerebral Amyloid Angiopathy.Amyloid-PET burden and regional distribution in cerebral amyloid angiopathy: a systematic review and meta-analysis of biomarker performance.Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis.Cortical Superficial Siderosis Presumed due to Cerebral Amyloid Angiopathy: Minimum Standards for Rating and Reporting.Author Correction: Distinctive Clinical Effects of Haemorrhagic Markers in Cerebral Amyloid Angiopathy.Consensus Needed for Noncontrast CT Markers in Intracerebral Hemorrhage.Convexity subarachnoid hemorrhage in lobar intracerebral hemorrhage: A prognostic markerAdvancing diagnostic criteria for sporadic cerebral amyloid angiopathy: Study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0.White matter hyperintensity burden in patients with ischemic stroke treated with thrombectomyMicrobleeds evolution and remote hemorrhage post-tPA: "Red meets white" revisitedHistopathology of diffusion imaging abnormalities in cerebral amyloid angiopathyCortical superficial siderosis and bleeding risk in cerebral amyloid angiopathy: A meta-analysisDistribution of cerebral microbleeds in the East and West: Individual participant meta-analysisCortical superficial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large prospective cohort and preliminary meta-analysisCortical superficial siderosis progression in cerebral amyloid angiopathy: Prospective MRI studyPotential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIAAPOE and cortical superficial siderosis in CAA: Meta-analysis and potential mechanisms
P50
Q47117098-D54DCC4C-CF33-4B69-8CF7-73A9111EF891Q47717893-FD652D65-0755-45A3-A9B8-286E4C5C17D4Q47798068-88C5D3EA-1F85-41E0-B51E-55E62DB433C7Q48229518-9F825B30-71FE-47C9-B26C-955A1603DF99Q55021777-B7F2B401-7DDC-4A0A-9B0B-833E515DD621Q64895559-03082AAE-EC17-4E2F-9501-15D2A6E4B212Q89531322-0725790B-323F-4A06-AA0F-4ECE7BA60CE6Q90081292-F25D37CF-2F71-4727-8A54-51866D371F79Q90100113-218A3DBE-3E9C-4687-9F24-77BA5AA7C94DQ91185654-EC61B9C5-6B17-4FC6-B8A1-8CE24AB45B7AQ91283159-CD107E9F-7F91-4758-8C20-3A65750D58B6Q91302402-EFD3D578-1463-419B-97CE-5D4423F388A8Q91312059-54701F04-5C81-43E6-AA97-6907100376B8Q91743518-955D151E-44AA-4224-B238-D01C65F5BC2CQ91873174-0AE2D387-BCA4-45BF-937B-88EF86E2D0CBQ92184705-2D298618-48AA-4A9C-8B1B-09C7322DFDA3Q93051526-7BDE9FB4-8E08-4ACB-8061-A3C3251CC720
P50
description
researcher
@en
wetenschapper
@nl
name
A Charidimou
@en
A Charidimou
@nl
type
label
A Charidimou
@en
A Charidimou
@nl
prefLabel
A Charidimou
@en
A Charidimou
@nl
P31
P496
0000-0001-5891-337X